Basic metabolic and vascular effects of ketamine and its interaction with fentanyl. (1st May 2023)

• Record Type: Journal Article
• Authors: Irwin, Matthew R.; Curay, Carlos M.; Choi, Shinbe; Kiyatkin, Eugene A.
• Is Part Of: Neuropharmacology. Volume 228(2023)
• Publication Date: 2023-05-01
• Subjects: Brain temperature -- Brain oxygen -- Hyperoxia -- Metabolic brain activation -- Peripheral vasoconstriction -- Oxygen sensors -- Respiratory depression -- Brain hypoxia; Neuropsychopharmacology -- Periodicals; Autonomic Agents -- Periodicals; Neuropsychopharmacologie -- Périodiques; Neuropsychopharmacology; Periodicals; Electronic journals; 615.78
• DOI: 10.1016/j.neuropharm.2023.109465
• Languages: English
• ISSNs: 0028-3908

Abstract

Abstract: Ketamine is a short-acting general anesthetic with hallucinogenic, analgesic, and amnestic properties. In addition to its anesthetic use, ketamine is commonly abused in rave settings. While safe when used by medical professionals, uncontrolled recreational use of ketamine is dangerous, especially when mixed with other sedative drugs, including alcohol, benzodiazepines, and opioid drugs. Since synergistic antinociceptive interactions between opioids and ketamine were demonstrated in both preclinical and clinical studies, such an interaction could exist for the hypoxic effects of opioid drugs. Here, we focused on the basic physiological effects of ketamine as a recreational drug and its possible interactions with fentanyl—a highly potent opioid that induces strong respiratory depression and robust brain hypoxia. By using multi-site thermorecording in freely-moving rats, we showed that intravenous ketamine at a range of human relevant doses (3, 9, 27 mg/kg) dose-dependently increases locomotor activity and brain temperature, as assessed in the nucleus accumbens (NAc). By determining temperature differentials between the brain, temporal muscle, and skin, we showed that the brain hyperthermic effect of ketamine results from increased intracerebral heat production, an index of metabolic neural activation, and decreased heat loss due to peripheral vasoconstriction. By using oxygen sensors coupled with high-speed amperometry we showed that ketamine at the same doses increases NAc oxygen levels. Finally, co-administration of ketamine with intravenous fentanyl results in modest enhancement of fentanyl-induced brain hypoxia also enhancing the post-hypoxic oxygen increase. Therefore, in contrast to fentanyl, ketamine increases brain oxygenation but potentiates brain hypoxia induced by fentanyl. Highlights: Iv ketamine dose-dependently increases locomotor activity and brain temperature. Hyperthermic effects of ketamine result from metabolic brain activation and peripheral vasoconstriction. Similar to natural arousing stimuli, Iv ketamine increases brain oxygen levels. Ketamine modestly enhances brain hypoxia induced by iv fentanyl. Ketamine also enhances post-hypoxic brain oxygen increases induced by fentanyl.